Lombard Odier Asset Management (USA)’s Cymabay Therapeutics CBAY Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-145,000	Closed	-$284K	–	237
2019 Q4	$284K	Hold	145,000	–	–	0.03%	166
2019 Q3	$742K	Hold	145,000	–	–	0.07%	139
2019 Q2	$1.04M	Sell	145,000 -35,000	-19%	-$251K	0.08%	112
2019 Q1	$2.39M	Sell	180,000 -39,495	-18%	-$524K	0.2%	75
2018 Q4	$1.73M	Sell	219,495 -78,566	-26%	-$618K	0.14%	98
2018 Q3	$3.3M	Sell	298,061 -80,939	-21%	-$897K	0.24%	74
2018 Q2	$5.09M	Sell	379,000 -25,000	-6%	-$335K	0.33%	56
2018 Q1	$5.25M	Sell	404,000 -117,247	-22%	-$1.52M	0.38%	51
2017 Q4	$4.8M	Sell	521,247 -3,753	-0.7%	-$34.5K	0.37%	56
2017 Q3	$4.23M	Sell	525,000 -1,665	-0.3%	-$13.4K	0.3%	68
2017 Q2	$3.03M	Hold	526,665	–	–	0.24%	76
2017 Q1	$2.27M	Sell	526,665 -50,000	-9%	-$215K	0.21%	97
2016 Q4	$998K	Sell	576,665 -50,313	-8%	-$87.1K	0.13%	102
2016 Q3	$1.22M	Sell	626,978 -26,238	-4%	-$50.9K	0.11%	148
2016 Q2	$1.14M	Sell	653,216 -56,224	-8%	-$97.9K	0.14%	126
2016 Q1	$958K	Sell	709,440 -376,241	-35%	-$508K	0.13%	132
2015 Q4	$1.84M	Sell	1,085,681 -12,517	-1%	-$21.2K	0.18%	116
2015 Q3	$2.13M	Buy	1,098,198 +356,072	+48%	+$691K	0.19%	133
2015 Q2	$2M	Sell	742,126 -568,874	-43%	-$1.53M	0.14%	137
2015 Q1	$9.07M	Sell	1,311,000 -57,557	-4%	-$398K	0.72%	34
2014 Q4	$13.5M	Buy	1,368,557 +118,557	+9%	+$1.17M	0.92%	23
2014 Q3	$8.55M	Buy	+1,250,000	New	+$8.55M	0.59%	40